Skip to content

ProQR Therapeutics NV Sustainability Reports

ProQR Therapeutics NV specializes in the development of RNA-based therapeutics to address severe genetic rare diseases.

Sector: Health Care

Country: Netherlands

Exchange: Nasdaq Stock Market

ISIN: NL0010872495

12 reports from 2014 to 2025